These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7828778)

  • 1. [Gliclazide: review of metabolic and vascular action].
    Alberti KG
    Diabete Metab; 1994 Nov; 20(3 Pt 2):341-8. PubMed ID: 7828778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gliclazide: metabolic and vascular effects--a perspective.
    Alberti KG; Johnson AB; Taylor R
    Metabolism; 1992 May; 41(5 Suppl 1):40-5. PubMed ID: 1574015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gliclazide and insulin action in human muscle.
    Bak JF; Pedersen O
    Diabetes Res Clin Pract; 1991; 14 Suppl 2():S61-4. PubMed ID: 1794267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular benefits of gliclazide beyond glycemic control.
    Jennings PE
    Metabolism; 2000 Oct; 49(10 Suppl 2):17-20. PubMed ID: 11078471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus.
    Palmer KJ; Brogden RN
    Drugs; 1993 Jul; 46(1):92-125. PubMed ID: 7691511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mode of action and clinical pharmacology of gliclazide: a review.
    Campbell DB; Lavielle R; Nathan C
    Diabetes Res Clin Pract; 1991; 14 Suppl 2():S21-36. PubMed ID: 1794262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular action of the hypoglycaemic agent gliclazide in diabetic rabbits.
    Pagano PJ; Griswold MC; Ravel D; Cohen RA
    Diabetologia; 1998 Jan; 41(1):9-15. PubMed ID: 9498623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic retinopathy in non-insulin-dependent diabetes mellitus patients: the role of gliclazide.
    Akanuma Y; Kosaka K; Kanazawa Y; Kasuga M; Fukuda M; Aoki S
    Am J Med; 1991 Jun; 90(6A):74S-76S. PubMed ID: 1872308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidant and vascular effects of gliclazide in type 2 diabetic rats fed high-fat diet.
    Sena CM; Louro T; Matafome P; Nunes E; Monteiro P; Seiça R
    Physiol Res; 2009; 58(2):203-209. PubMed ID: 18380531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The physiological action of gliclazide: beta-cell function and insulin resistance.
    Matthews DR; Hosker JP; Stratton I
    Diabetes Res Clin Pract; 1991; 14 Suppl 2():S53-9. PubMed ID: 1794266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemobiological activity of gliclazide in diabetes mellitus.
    Ziegler O; Drouin P
    Diabetes Res Clin Pract; 1991; 14 Suppl 2():S83-9. PubMed ID: 1794271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effect of gliclazide on platelet aggregation in insulin-treated and non-insulin-treated diabetes: a two-year controlled study.
    Larkins RG; Jerums G; Taft JL; Godfrey H; Smith IL; Martin TJ
    Diabetes Res Clin Pract; 1988 Jan; 4(2):81-7. PubMed ID: 3125029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gliclazide modified release: A critical review of pharmacodynamic, metabolic, and vasoprotective effects.
    Schernthaner G
    Metabolism; 2003 Aug; 52(8 Suppl 1):29-34. PubMed ID: 12939737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocyte adhesion in diabetic angiopathy: effects of free-radical scavenging.
    Renier G; Mamputu JC; Desfaits AC; Serri O
    J Diabetes Complications; 2003; 17(2 Suppl):20-9. PubMed ID: 12623165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemobiological properties of gliclazide.
    Ziegler O; Drouin P
    J Diabetes Complications; 1994; 8(4):235-9. PubMed ID: 7833500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Physiopathology of non insulin-dependent diabetes. Action of gliclazide].
    Lesobre B
    Journ Annu Diabetol Hotel Dieu; 1985; ():319-23. PubMed ID: 2577975
    [No Abstract]   [Full Text] [Related]  

  • 17. Postreceptor effects of sulfonylurea on skeletal muscle glycogen synthase activity in type II diabetic patients.
    Bak JF; Schmitz O; Sørensen NS; Pedersen O
    Diabetes; 1989 Nov; 38(11):1343-50. PubMed ID: 2559864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The action of gliclazide on insulin secretion and insulin sensitivity in non-obese non-insulin dependent diabetic patients.
    Chang TC; Wang LM; Cheng CY; Kuo HF; Liu PC; Ho LT
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Aug; 46(2):79-85. PubMed ID: 2177368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From hemobiology to vascular disease: a review of the potential of gliclazide to influence the pathogenesis of diabetic vascular disease.
    Jennings PE
    J Diabetes Complications; 1994; 8(4):226-30. PubMed ID: 7833498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of long term gliclazide administration on insulin secretion and insulin sensitivity.
    Ma A; Kamp M; Bird D; Howlett V; Cameron DP
    Aust N Z J Med; 1989 Feb; 19(1):44-9. PubMed ID: 2669710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.